Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy

Схожие документы

• Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy
  по: Yoon Sang, et al.
  Опубликовано: (2010-09-01)
• The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
  по: Shim, Hyun-Jeong, et al.
  Опубликовано: (2016)
• Prognostic significance of neutropenia during adjuvant concurrent chemoradiotherapy in early cervical cancer
  по: Kim, Yun Hwan, et al.
  Опубликовано: (2009)
• Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
  по: Hundo Cho, et al.
  Опубликовано: (2022-05-01)
• Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
  по: Gun Oh Chong, et al.
  Опубликовано: (2015-01-01)